Lausanne, Switzerland - March 11, 2021 - Saphetor SA, a Swiss-based precision medicine company specializing in analysis and interpretation of genomic data, announced today a distribution agreement with BioCat GmbH, a leading provider of innovative technologies, assays, reagents and comprehensive solutions tailored to the health & life science research sector, for Germany and Austria.
Under the terms of the agreement, BioCat GmbH will act as distribution partner for Saphetor's suite of VarSome bioinformatics tools for healthcare professionals and researchers throughout Germany and Austria.
VarSome is the emerging global standard platform for human genome data. The free-to-use variant search engine, VarSome.com, is relied on by researchers and clinicians around the world. VarSome is an active community project increasing global knowledge of variants in the human genome. Through BioCat's position as one of the leading distributors of Life Science tools in Germany and Austria, this partnership will help leverage the experience of a region with a rich history in clinical and scientific excellence.
Dr. Michael Hartmann, CEO at BioCat, said: ‘We are really excited to closely collaborate with Saphetor to bring their powerful VarSome platform even closer to the NGS community in Germany and Austria. We are constantly expanding our offerings with novel solutions and innovations. The VarSome Suit of bioinformatic tools by Saphetor for NGS analysis represents another very valuable addition to our already existing broad portfolio of high quality NGS products.’
Tomas Kucera, Head of Business Development at Saphetor SA, commented: ‘We are thrilled to announce new collaboration with BioCat GmbH as VarSome's channel partner for Germany and Austria, and we are ready to work closely with BioCat's highly knowledgeable and motivated team to accelerate the adoption of NGS technology in clinical and clinical-research settings.’